Mengfeng Li
Impact in
- Cancer Research top 0.2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 1%
- Circular RNAs in diseases
- RNA modifications and cancer
- Epigenetics and DNA Methylation
Papers in
-
- Circular RNAs in diseases 13
- Angiogenesis and VEGF in Cancer 11
- RNA modifications and cancer 10
- Epigenetics and DNA Methylation 9
-
- MicroRNA in disease regulation 20
- Cancer-related molecular mechanisms research 17
- NF-κB Signaling Pathways 9
- Co-authors
- Jueheng Wu (81 shared papers)Jun Li (36 shared papers)Junchao Cai (32 shared papers)Xun Zhu (46 shared papers)Libing Song (27 shared papers)Jie Yuan (24 shared papers)Lishan Fang (12 shared papers)Erwei Song (10 shared papers)
- Journals
- PLoS ONE (8 papers)Cancer Research (7 papers)International Journal of Cancer (7 papers)Clinical Cancer Research (7 papers)Nature Communications (6 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Mengfeng Li
140 papers receiving 9.5k citations
Mengfeng Li's Hit Papers
Peers
Comparison fields: 5 of 141
- Cancer Research 3.2k
- Molecular Biology 5.4k
- Oncology 1.9k
- Immunology 1.0k
- Pathology and Forensic Medicine 626
Countries citing papers authored by Mengfeng Li
This map shows the geographic impact of Mengfeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengfeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengfeng Li more than expected).
Fields of papers citing papers by Mengfeng Li
This network shows the impact of papers produced by Mengfeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengfeng Li. The network helps show where Mengfeng Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Mengfeng Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 143 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness Hit paper breakdown → | 2018 | 959 |
| 2 | Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells Hit paper breakdown → | 2019 | 600 |
| 3 | 2013 | 310 | |
| 4 | 2008 | 276 | |
| 5 | 2013 | 177 | |
| 6 | 2015 | 169 | |
| 7 | 2012 | 169 | |
| 8 | 2011 | 168 | |
| 9 | 2009 | 167 | |
| 10 | 2017 | 154 | |
| 11 | 2011 | 140 | |
| 12 | 2010 | 139 | |
| 13 | 2011 | 137 | |
| 14 | 2008 | 134 | |
| 15 | 2010 | 132 | |
| 16 | 2012 | 131 | |
| 17 | 2011 | 131 | |
| 18 | 2017 | 126 | |
| 19 | 2011 | 125 | |
| 20 | 2004 | 121 |
About Mengfeng Li
Mengfeng Li is a scholar working on Molecular Biology, Cancer Research, Oncology, Epidemiology and Pathology and Forensic Medicine, having authored 143 papers that have together received 9.6k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (20 papers), Cancer-related molecular mechanisms research (17 papers), Circular RNAs in diseases (13 papers), Cancer Mechanisms and Therapy (12 papers), Angiogenesis and VEGF in Cancer (11 papers), RNA modifications and cancer (10 papers), Epigenetics and DNA Methylation (9 papers) and NF-κB Signaling Pathways (9 papers). The work is most often cited by research in Cancer Research (3.2k citations), Molecular Biology (5.4k citations), Oncology (1.9k citations), Immunology (1.0k citations) and Pathology and Forensic Medicine (626 citations). Mengfeng Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jueheng Wu, Jun Li, Junchao Cai, Xun Zhu, Libing Song, Jie Yuan, Lishan Fang, Erwei Song, Zhe Ying and Yi Yang. Their work appears in journals such as PLoS ONE, Cancer Research, International Journal of Cancer, Clinical Cancer Research and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.